Association of PD-1.9 polymorphism with the risk of HBV-related hepatocellular carcinoma

Tài liệu liên quan:

• Efficacy and safety of PD-1/PD-L1 inhibitors combined with anti-angiogenic therapy for the unresectable hepatocellular carcinoma and the benefit for hepatitis B virus etiology subgroup: A systematic review and meta-analysis of randomized controlled trials

  11 trang 20 0 0

• khả năng điều trị virus viêm gan siêu vi C (tt)

  12 trang 16 0 0

• Association between interleukin-18 polymorphisms and hepatocellular carcinoma occurrence and clinical progression

  6 trang 10 0 0

• Seroprevalence of HIV, HBV, HCV and VDRL among voluntary donors in a tertiary care hospital

  3 trang 10 0 0

• Thực trạng mang HBsAg và một số yếu tố liên quan tới nhiễm virus viêm gan B ở thuyền viên

  7 trang 10 0 0

• Hepatocellular carcinoma in occult hepatitis B virus infection: A case report

  4 trang 9 0 0

• The association of HBV infection and head and neck cancer: A systematic review and meta-analysis

  10 trang 9 0 0

• PD-1.1 polymorphism associates with liver cirrhosis caused by chronic HBV infection

  6 trang 8 0 0

• Both chronic HBV infection and naturally acquired HBV immunity confer increased risks of B-cell non-Hodgkin lymphoma

  8 trang 7 0 0

• Prevalence of non-responders among medical laboratory technicians and staff nurses evaluated for anti hepatitis B surface antigen titre

  7 trang 7 0 0